SUMMARY
Psoriasis is a chronic relapsing and remitting autoimmune condition which presents as erythematous, well-defined plaques with silvery white scales. The lesions commonly occur on the extensor aspects of the limbs and trunk. There may be associated scalp, palms, soles, and nail involvement. Psoriasiform drug eruption is defined as heterogeneous group of disorders characterized by clinical or histological resemblance to psoriasis at some points during a disease. Drugs may be responsible for precipitation of psoriasis de novo, exacerbation of preexisting psoriasis, and development of treatment-resistant psoriasis. Clinically, drug-provoked psoriasis can present as generalized plaque psoriasis, palmoplantar pustulosis, or erythroderma. Histologically, there are parakeratosis, presence of granular layer, psoriasiform epidermal hyperplasia, but no evidence of suprapapillary thinning or dilated capillaries. They may resolve after withdrawal of the offending drug. Some features which are helpful in distinguishing psoriasis from psoriasiform drug eruption are enlisted in Table 
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